{"title":"Awareness and Attitudes Toward Medication-Related Osteonecrosis of the Jaw Among Physicians: A Cross-Sectional Study","authors":"Kadriye Ayça Dere, Ayşe Güllü","doi":"10.1155/ijcp/1684494","DOIUrl":null,"url":null,"abstract":"<p><b>Background:</b> The aim of this study was to evaluate the knowledge and attitudes of medical physicians who prescribe antiresorptive and antiangiogenic drugs toward medication-related osteonecrosis of the jaw (MRONJ), a devastating complication.</p><p><b>Methods:</b> This cross-sectional study included physicians in the fields of internal medicine, orthopedics and traumatology, rheumatology, physical medicine and rehabilitation, oncology, hematology, and urology working in university hospitals, training and research hospitals, and private health institutions. Participating physicians were asked to answer a survey consisting of 25 questions to determine their knowledge, attitudes, and awareness about MRONJ.</p><p><b>Results:</b> Of the physicians participating in the study, 45% were academicians, 30.9% were specialists, and 24.2% were assistant physicians. 30.3% of the participate had never heard of the concept of MRONJ. The specialties most aware of the concept of MRONJ were internal medicine (21.74%), physical medicine and rehabilitation (18.26%), and orthopedics and traumatology (17.39%), respectively. In our study, it was determined that 38.78% of the participants did not receive information on this subject through lectures/presentations/seminars, etc., and 10.8% reported that they were not informed about the side effects of drugs that can cause MRONJ. 37% of the physicians never consulted their patients with a dentist before starting treatment with drugs that can cause MRONJ.</p><p><b>Conclusions:</b> The study results showed that physicians who prescribe drugs that can cause MRONJ have low awareness of preventing MRONJ and that their knowledge and sensitivity on this issue should be increased.</p>","PeriodicalId":13782,"journal":{"name":"International Journal of Clinical Practice","volume":"2025 1","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ijcp/1684494","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/ijcp/1684494","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The aim of this study was to evaluate the knowledge and attitudes of medical physicians who prescribe antiresorptive and antiangiogenic drugs toward medication-related osteonecrosis of the jaw (MRONJ), a devastating complication.
Methods: This cross-sectional study included physicians in the fields of internal medicine, orthopedics and traumatology, rheumatology, physical medicine and rehabilitation, oncology, hematology, and urology working in university hospitals, training and research hospitals, and private health institutions. Participating physicians were asked to answer a survey consisting of 25 questions to determine their knowledge, attitudes, and awareness about MRONJ.
Results: Of the physicians participating in the study, 45% were academicians, 30.9% were specialists, and 24.2% were assistant physicians. 30.3% of the participate had never heard of the concept of MRONJ. The specialties most aware of the concept of MRONJ were internal medicine (21.74%), physical medicine and rehabilitation (18.26%), and orthopedics and traumatology (17.39%), respectively. In our study, it was determined that 38.78% of the participants did not receive information on this subject through lectures/presentations/seminars, etc., and 10.8% reported that they were not informed about the side effects of drugs that can cause MRONJ. 37% of the physicians never consulted their patients with a dentist before starting treatment with drugs that can cause MRONJ.
Conclusions: The study results showed that physicians who prescribe drugs that can cause MRONJ have low awareness of preventing MRONJ and that their knowledge and sensitivity on this issue should be increased.
期刊介绍：
IJCP is a general medical journal. IJCP gives special priority to work that has international appeal.
IJCP publishes:
Editorials. IJCP Editorials are commissioned. [Peer reviewed at the editor''s discretion]
Perspectives. Most IJCP Perspectives are commissioned. Example. [Peer reviewed at the editor''s discretion]
Study design and interpretation. Example. [Always peer reviewed]
Original data from clinical investigations. In particular: Primary research papers from RCTs, observational studies, epidemiological studies; pre-specified sub-analyses; pooled analyses. [Always peer reviewed]
Meta-analyses. [Always peer reviewed]
Systematic reviews. From October 2009, special priority will be given to systematic reviews. [Always peer reviewed]
Non-systematic/narrative reviews. From October 2009, reviews that are not systematic will be considered only if they include a discrete Methods section that must explicitly describe the authors'' approach. Special priority will, however, be given to systematic reviews. [Always peer reviewed]
''How to…'' papers. Example. [Always peer reviewed]
Consensus statements. [Always peer reviewed] Short reports. [Always peer reviewed]
Letters. [Peer reviewed at the editor''s discretion]
International scope
IJCP publishes work from investigators globally. Around 30% of IJCP articles list an author from the UK. Around 30% of IJCP articles list an author from the USA or Canada. Around 45% of IJCP articles list an author from a European country that is not the UK. Around 15% of articles published in IJCP list an author from a country in the Asia-Pacific region.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
